Threatened late miscarriage. French guidelines;Menace de fausse couche tardive. Recommandations françaises

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 10, 2014, Pages 842-855

  Carcopino, X ^a,b   Barde, K ^a   Petrovic, M ^a   Beucher, G ^c   Capmas, P ^d,e   Huchon, C ^f,g   Deffieux, X ^h   DgErcole, C ^a   Bretelle, F ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^g Risques Cliniques et Securite en Sante des Femmes et en Sante Perinatale   (France)

^h HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Antibiotics; Bacterial vaginosis; Cerclage; Cervical length; Late miscarriage; Membrane prolapse; Progesteronetherapy

Indexed keywords

ANTIBIOTIC AGENT; INDOMETACIN; PROGESTERONE;

ANAMNESIS; ARTICLE; CERVICAL LENGTH MEASUREMENT; FRANCE; GESTATIONAL AGE; HUMAN; IMMINENT ABORTION; PRACTICE GUIDELINE; PREMATURE LABOR; RECOMMENDED DRUG DOSE; SYSTEMATIC REVIEW; THREATENED LATE MISCARRIAGE; TRANSVAGINAL ECHOGRAPHY; TREATMENT PLANNING; UTERINE CERVIX CERCLAGE; ABORTION, SPONTANEOUS; FEMALE; PREGNANCY; SECOND TRIMESTER PREGNANCY; STANDARDS;

ABORTION, SPONTANEOUS; FEMALE; FRANCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 84920012517     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.09.015     Document Type: Article

References (49)

1. Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Vanden Bosch T, Riphagen I, et al. Predictive value for pretermbirth of abnormal vaginal flora, bacterial vaginosis and aero-bic vaginitis during the first trimester of pregnancy. BJOG2009; 116: 1315-24.
2. Yamada T, Morikawa M, Yamada T, Kishi R, Sengoku K, Endo T, et al. First trimester serum folate levels and subsequent riskof abortion and preterm birth among Japanese women withsingleton pregnancies. Arch Gynecol Obstet 2013; 287: 9-14.
3. Wyatt PR, Owolabi T, Meier C, Huang T. Age-specific risk of fetalloss observed in a second trimester serum screening popula-tion. Am J Obstet Gynecol 2005; 192: 240-6.
4. Berghella V, Keeler SM, To MS, Althuisius SM, Rust OA. Effectiveness of cerclage according to severity of cervicallength shortening: a meta-analysis. Ultrasound Obstet Gynecol2010; 35: 468-73.
5. Vaisbuch E, Romero R, Erez O, Kusanovic JP, Mazaki-Tovi S, Gotsch F, et al. Clinical significance of early (< 20 weeks) vslate (20-24 weeks) detection of sonographic short cervix inasymptomatic women in the mid-trimester. Ultrasound ObstetGynecol 2010; 36: 471-81.
6. Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kusanovic JP, Mittal P, et al. The risk of impending preterm delivery in asymp-tomatic patients with a nonmeasurable cervical length in thesecond trimester. Am J Obstet Gynecol 2010; 203: 446e1-9e.
7. Althuisius SM, Dekker GA, Hummel P, van Geijn HP. Cervicalincompetence prevention randomized cerclage trial: emer-gency cerclage with bed rest versus bed rest alone. Am J ObstetGynecol 2003; 189: 907-10.
8. Ancel PY, Saurel-Cubizolles MJ, Di Renzo GC, Papiernik E, Breart G. Risk factors for 14-21 week abortions: a case-control studyin Europe. The Europop Group. Hum Reprod 2000; 15: 2426-32.
9. Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Mana-gement of cervical insufficiency and bulging fetal membranes. Obstet Gynecol 2006; 107: 221-6.
10. Fuchs F, Bouyer J, Fernandez H, Gervaise A, Frydman R, Senat MV. Ultrasound cervical length measurement for predic-tion of delivery before 32 weeks in women with emergencycerclage for cervical insufficiency. Int J Gynaecol Obstet2010; 110: 245-8.
11. Berghella V, Owen J, MacPherson C, Yost N, Swain M, Dildy3rd GA, et al. Natural history of cervical funneling in womenat high risk for spontaneous preterm birth. Obstet Gynecol2007; 109: 863-9.
12. To MS, Skentou C, Liao AW, Cacho A, Nicolaides KH. Cervicallength and funneling at 23 weeks of gestation in the predic-tion of spontaneous early preterm delivery. Ultrasound ObstetGynecol 2001; 18: 200-3.
13. Mancuso MS, Szychowski JM, Owen J, Hankins G, Iams JD, Shef-field JS, et al. Cervical funneling: effect on gestational lengthand ultrasound-indicated cerclage in high-risk women. Am JObstet Gynecol 2010; 203: 259e1-5e.
14. Kusanovic JP, Espinoza J, Romero R, Goncalves LF, Nien JK, Soto E, et al. Clinical significance of the presence of amnioticfluid "sludge" in asymptomatic patients at high risk for spon-taneous preterm delivery. Ultrasound Obstet Gynecol 2007; 30: 706-14.
15. Pires CR, Moron AF, Mattar R, Diniz AL, Andrade SG, BussamraLC. Cervical gland area as an ultrasonographic marker for pre-term delivery. Int J Gynaecol Obstet 2006; 93: 214-9.
16. Fukami T, Ishihara K, Sekiya T, Araki T. Is transvaginal ultrasono-graphy at mid-trimester useful for predicting early spontaneouspreterm birth? J Nippon Med School 2003; 70: 135-40.
17. Berghella V, Tolosa JE, Kuhlman K, Weiner S, Bolognese RJ, Wapner RJ. Cervical ultrasonography compared with manualexamination as a predictor of preterm delivery. Am J ObstetGynecol 1997; 177: 723-30.
18. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics fortreating bacterial vaginosis in pregnancy. Cochrane Dat SystRev 2013; 1: CD000262.
19. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and inter-mediate flora as risk factors for adverse pregnancy outcome. Best Pract Res 2007; 21: 375-90.
20. Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, ZamoraJ, Schlattmann P. The short-term prediction of preterm birth: a systematic review and diagnostic meta-analysis. Am J ObstetGynecol 2014; 210: 54e1-610e.
21. Acharya G, Eschler B, Gronberg M, Hentemann M, Ottersen T, Maltau JM. Noninvasive cerclage for the management of cer-vical incompetence: a prospective study. Arch Gynecol Obstet2006; 273: 283-7.
22. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khan-delwal M, et al. Vaginal progesterone reduces the rate ofpreterm birth in women with a sonographic short cervix: a mul-ticenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
23. Olatunbosun OA, Al-Nuaim L, Turnell RW. Emergency cerclagecompared with bed rest for advanced cervical dilatation inpregnancy. Int Surg 1995; 80: 170-4.
24. Miller ES, Grobman WA, Fonseca L, Robinson BK. Indome-thacin and antibiotics in examination-indicated cerclage: a randomized controlled trial. Obstet Gynecol 2014; 123: 1311-6.
25. ANSM. Répertoire des Spécialités Pharmaceutiques. [cited 201403 juillet 2014] ; Available from: www.ansm.sante.fr
26. Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervicalstitch (cerclage) for preventing preterm birth in singleton pre-gnancy. Cochrane Dat Syst Rev 2012; 4: CD008991.
27. Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for short cervix on ultrasonography in women with sin-gleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 2011; 117: 663-71.
28. Goya M, Pratcorona L, Merced C, Rodo C, Valle L, Romero A, et al. Cervical pessary in pregnant women with a short cer-vix (PECEP): an open-label randomised controlled trial. Lancet2012; 379: 1800-6.
29. Arabin B, Halbesma JR, Vork F, Hubener M, van Eyck J. Is treatment with vaginal pessaries an option in patientswith a sonographically detected short cervix? J Perinat Med2003; 31: 122-33.
30. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pes-sary for preventing preterm birth. Cochrane Dat Syst Rev2013; 5: CD007873.
31. Hui SY, Chor CM, Lau TK, Lao TT, Leung TY. Cerclage pessary forpreventing preterm birth in women with a singleton pregnancyand a short cervix at 20 to 24 weeks: a randomized controlledtrial. Am J Perinat 2013; 30: 283-8.
32. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Dat Syst Rev 2013; 10: CD003511.
33. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenataladministration of progesterone for preventing preterm birth inwomen considered to be at risk of preterm birth. Cochrane DatSyst Rev 2013; 7: CD004947.
34. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, et al. Vaginal progesterone in women with anasymptomatic sonographic short cervix in the mid-trimesterdecreases preterm delivery and neonatal morbidity: a syste-matic review and meta-analysis of individual patient data. AmJ Obstet Gynecol 2012; 206: 124e1-319e.
35. Larsson PG, Fahraeus L, Carlsson B, Jakobsson T, Forsum U. Latemiscarriage and preterm birth after treatment with clindamy-cin: a randomised consent design study according to Zelen. BJOG 2006; 113: 629-37.
36. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of earlyoral clindamycin on late miscarriage and preterm deliveryin asymptomatic women with abnormal vaginal flora andbacterial vaginosis: a randomised controlled trial. Lancet2003; 361: 983-8.
37. Darwish A, Elnshar EM, Hamadeh SM, Makarem MH. Treatmentoptions for bacterial vaginosis in patients at high risk of pre-term labor and premature rupture of membranes. J ObstetGynaecol Res 2007; 33: 781-7.
38. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van GeijnHP. Final results of the Cervical Incompetence PreventionRandomized Cerclage Trial (CIPRACT): therapeutic cerclagewith bed rest versus bed rest alone. Am J Obstet Gynecol2001; 185: 1106-12.
39. Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, et al. Multicenter randomized trial of cerclagefor preterm birth prevention in high-risk women with shor-tened mid-trimester cervical length. Am J Obstet Gynecol2009; 201: 375e1-8e.
40. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention ofpreterm birth in women with a short cervix found on transva-ginal ultrasound examination: a randomized trial. Am J ObstetGynecol 2004; 191: 1311-7.
41. To MS, Alfirevic Z, Heath VC, Cicero S, Cacho AM, Williamson PR, et al. Cervical cerclage for prevention of preterm deli-very in women with short cervix: randomised controlled trial. Lancet 2004; 363: 1849-53.
42. Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J. Revisi-ting the short cervix detected by transvaginal ultrasound inthe second trimester: why cerclage therapy may not help. AmJ Obstet Gynecol 2001; 185: 1098-105.
43. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrentpreterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol2007; 30: 687-96.
44. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progeste-rone and the risk of preterm birth among women with a shortcervix. New Engl J Med 2007; 357: 462-9.
45. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet2011; 283: 423-9.
46. Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A. Prevention of preterm delivery in twin gestations (PRE-DICT): a multicenter, randomized, placebo-controlled trial onthe effect of vaginal micronized progesterone. Ultrasound Obs-tet Gynecol 2011; 38: 272-80.
47. Keeler SM, Kiefer D, Rochon M, Quinones JN, Novetsky AP, Rust O. A randomized trial of cerclage vs 17 alpha-hydroxyprogesterone caproate for treatment of short cervix. J Perinat Med 2009; 37: 473-9.
48. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, et al. Vaginal progesterone vs. cervicalcerclage for the prevention of preterm birth in women with asonographic short cervix, previous preterm birth, and singletongestation: a systematic review and indirect comparison meta-analysis. Am J Obstet Gynecol 2013; 208: 42e1-518e.
49. Miller ES, Grobman WA, Fonseca L, Robinson BK. Indometha-cin and antibiotics in examination-indicated cerclage. ObstetGynecol 2014; 123: 1311-6.